Mesenchymal stromal cells transiently alter the inflammatory milieu
- Slides: 7
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versushost disease by Melinda E. Christensen, Brie E. Turner, Laura J. Sinfield, Katarina Kollar, Hannah Cullup, Nigel J. Waterhouse, Derek N. J. Hart, Kerry Atkinson, and Alison M. Rice haematol Volume 95(12): 2102 -2110 December 1, 2010 © 2010 by Ferrata Storti Foundation
MSC suppress T-cell proliferation and inflammatory cytokines in vitro. Melinda E. Christensen et al. Haematologica 2010; 95: 21022110 © 2010 by Ferrata Storti Foundation
MSC administered 24 h post-transplant delay death from GVHD after MHC-mismatched HSCT. BALB/c mice (n=28 controls, n=18 MSC treated, 4 independent experiments) were transplanted with UBI-GFP/BL 6 bone marrow and splenocytes and treated mice administered dono. . . Melinda E. Christensen et al. Haematologica 2010; 95: 21022110 © 2010 by Ferrata Storti Foundation
MSC cause changes in IFNγ after MHC-mismatched HSCT. BALB/c mice were transplanted with UBI-GFP/BL 6 bone marrow and splenocytes ± MSC on day +1. Melinda E. Christensen et al. Haematologica 2010; 95: 21022110 © 2010 by Ferrata Storti Foundation
MSC do not contribute to healing of GVHD target organs. Melinda E. Christensen et al. Haematologica 2010; 95: 21022110 © 2010 by Ferrata Storti Foundation
Impact of IFNγ pre-treatment of MSC, T-cell depletion or cyclosporine on survival after MHC mismatched HSCT. (A) BALB/c mice (n=12 controls, n=12 MSC treated, n=6 per remaining treatment groups, 2 independent experiments) were transplanted with UBI-GFP/BL 6. . . Melinda E. Christensen et al. Haematologica 2010; 95: 21022110 © 2010 by Ferrata Storti Foundation
Survival is increased after low dose MSC are infused 24 h after MHC-matched, mi. HA mismatched HSCT. BALB. B mice were transplanted with UBI-GFP/BL 6 bone marrow and splenocytes and administered at a low (4× 105/mouse) or high (1× 106/mouse) dose of MSC on day +1. . . Melinda E. Christensen et al. Haematologica 2010; 95: 21022110 © 2010 by Ferrata Storti Foundation